

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative T cell selection (GO:0043383) | 7.57181079 |
| 2 | positive regulation of gamma-delta T cell activation (GO:0046645) | 7.53185276 |
| 3 | negative thymic T cell selection (GO:0045060) | 7.03115293 |
| 4 | interferon-gamma production (GO:0032609) | 6.98064568 |
| 5 | negative regulation of cell killing (GO:0031342) | 6.98021549 |
| 6 | negative regulation of leukocyte mediated cytotoxicity (GO:0001911) | 6.98021549 |
| 7 | regulation of isotype switching to IgG isotypes (GO:0048302) | 6.46281825 |
| 8 | positive regulation of antigen receptor-mediated signaling pathway (GO:0050857) | 6.45328997 |
| 9 | regulation of gamma-delta T cell differentiation (GO:0045586) | 6.33660638 |
| 10 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 6.33014014 |
| 11 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 6.33014014 |
| 12 | positive thymic T cell selection (GO:0045059) | 6.14703213 |
| 13 | positive T cell selection (GO:0043368) | 6.14614822 |
| 14 | thymic T cell selection (GO:0045061) | 5.87368465 |
| 15 | regulation of gamma-delta T cell activation (GO:0046643) | 5.71027965 |
| 16 | T cell selection (GO:0045058) | 5.67347623 |
| 17 | cytidine metabolic process (GO:0046087) | 5.51576654 |
| 18 | cytidine catabolic process (GO:0006216) | 5.51576654 |
| 19 | cytidine deamination (GO:0009972) | 5.51576654 |
| 20 | cellular response to interleukin-15 (GO:0071350) | 5.50502447 |
| 21 | response to interleukin-15 (GO:0070672) | 5.49674214 |
| 22 | leukocyte aggregation (GO:0070486) | 5.46162640 |
| 23 | T cell migration (GO:0072678) | 5.35097063 |
| 24 | antigen processing and presentation of endogenous antigen (GO:0019883) | 5.23363055 |
| 25 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 5.18523691 |
| 26 | T cell receptor signaling pathway (GO:0050852) | 5.12269666 |
| 27 | regulation of single stranded viral RNA replication via double stranded DNA intermediate (GO:0045091 | 4.99743662 |
| 28 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 4.93680433 |
| 29 | regulation of T cell tolerance induction (GO:0002664) | 4.87410809 |
| 30 | DNA deamination (GO:0045006) | 4.81413490 |
| 31 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.72255668 |
| 32 | T cell costimulation (GO:0031295) | 4.71267473 |
| 33 | lymphocyte costimulation (GO:0031294) | 4.67910057 |
| 34 | regulation of B cell receptor signaling pathway (GO:0050855) | 4.66219987 |
| 35 | regulation of T cell receptor signaling pathway (GO:0050856) | 4.57097118 |
| 36 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 4.40082768 |
| 37 | antigen receptor-mediated signaling pathway (GO:0050851) | 4.39195154 |
| 38 | mast cell activation (GO:0045576) | 4.37552583 |
| 39 | activated T cell proliferation (GO:0050798) | 4.34698539 |
| 40 | regulation of antigen receptor-mediated signaling pathway (GO:0050854) | 4.33109791 |
| 41 | regulation of natural killer cell mediated cytotoxicity (GO:0042269) | 4.24276747 |
| 42 | regulation of natural killer cell mediated immunity (GO:0002715) | 4.24276747 |
| 43 | positive regulation of natural killer cell mediated immunity (GO:0002717) | 4.22842590 |
| 44 | positive regulation of natural killer cell mediated cytotoxicity (GO:0045954) | 4.22842590 |
| 45 | positive regulation of alpha-beta T cell proliferation (GO:0046641) | 4.17272799 |
| 46 | regulation of alpha-beta T cell proliferation (GO:0046640) | 4.12667219 |
| 47 | positive regulation of isotype switching (GO:0045830) | 4.11920994 |
| 48 | positive regulation of tolerance induction (GO:0002645) | 4.11251195 |
| 49 | negative regulation of T cell mediated immunity (GO:0002710) | 4.05074325 |
| 50 | regulation of regulatory T cell differentiation (GO:0045589) | 3.95069831 |
| 51 | regulation of isotype switching (GO:0045191) | 3.91029904 |
| 52 | T cell differentiation (GO:0030217) | 3.88511614 |
| 53 | tolerance induction (GO:0002507) | 3.88231847 |
| 54 | regulation of leukocyte mediated cytotoxicity (GO:0001910) | 3.85516487 |
| 55 | positive regulation of leukocyte mediated cytotoxicity (GO:0001912) | 3.85432905 |
| 56 | positive regulation of immunoglobulin mediated immune response (GO:0002891) | 3.77049313 |
| 57 | positive regulation of B cell mediated immunity (GO:0002714) | 3.77049313 |
| 58 | antigen processing and presentation via MHC class Ib (GO:0002475) | 3.70636743 |
| 59 | regulation of immunoglobulin mediated immune response (GO:0002889) | 3.69880682 |
| 60 | alpha-beta T cell activation (GO:0046631) | 3.69629852 |
| 61 | positive regulation of granulocyte differentiation (GO:0030854) | 3.67342214 |
| 62 | sequestering of actin monomers (GO:0042989) | 3.67284739 |
| 63 | regulation of interleukin-2 biosynthetic process (GO:0045076) | 3.66249766 |
| 64 | positive regulation of DNA recombination (GO:0045911) | 3.65648036 |
| 65 | regulation of B cell mediated immunity (GO:0002712) | 3.64683341 |
| 66 | alpha-beta T cell differentiation (GO:0046632) | 3.63771619 |
| 67 | negative regulation of T cell apoptotic process (GO:0070233) | 3.63616876 |
| 68 | positive regulation of interleukin-2 production (GO:0032743) | 3.59210268 |
| 69 | negative regulation of T cell receptor signaling pathway (GO:0050860) | 3.58700505 |
| 70 | positive regulation of defense response to virus by host (GO:0002230) | 3.57952264 |
| 71 | regulation of cell killing (GO:0031341) | 3.57156005 |
| 72 | regulation of tolerance induction (GO:0002643) | 3.56766047 |
| 73 | lymphocyte chemotaxis (GO:0048247) | 3.54802605 |
| 74 | negative regulation of leukocyte mediated immunity (GO:0002704) | 3.52075404 |
| 75 | regulation of B cell differentiation (GO:0045577) | 3.51419526 |
| 76 | positive regulation of cell killing (GO:0031343) | 3.49787980 |
| 77 | regulation of T cell mediated cytotoxicity (GO:0001914) | 3.49258843 |
| 78 | regulation of response to interferon-gamma (GO:0060330) | 3.48684891 |
| 79 | T cell homeostasis (GO:0043029) | 3.47576688 |
| 80 | mast cell activation involved in immune response (GO:0002279) | 3.46861008 |
| 81 | mast cell degranulation (GO:0043303) | 3.46861008 |
| 82 | negative regulation of antigen receptor-mediated signaling pathway (GO:0050858) | 3.45786431 |
| 83 | positive regulation of calcium-mediated signaling (GO:0050850) | 3.45237784 |
| 84 | regulation of interferon-gamma-mediated signaling pathway (GO:0060334) | 3.45004538 |
| 85 | T cell activation (GO:0042110) | 3.43820551 |
| 86 | negative regulation of lymphocyte mediated immunity (GO:0002707) | 3.43774268 |
| 87 | regulation of lymphocyte chemotaxis (GO:1901623) | 3.41637696 |
| 88 | natural killer cell activation (GO:0030101) | 3.37677185 |
| 89 | positive regulation of T cell mediated immunity (GO:0002711) | 3.35569256 |
| 90 | regulation of T cell chemotaxis (GO:0010819) | 3.34550503 |
| 91 | positive regulation of T cell chemotaxis (GO:0010820) | 3.34550503 |
| 92 | leukocyte cell-cell adhesion (GO:0007159) | 3.31830680 |
| 93 | positive regulation of B cell differentiation (GO:0045579) | 3.29350405 |
| 94 | dendritic cell chemotaxis (GO:0002407) | 3.28190025 |
| 95 | positive regulation of humoral immune response (GO:0002922) | 3.26811718 |
| 96 | positive regulation of immune response to tumor cell (GO:0002839) | 3.26697461 |
| 97 | regulation of immune response to tumor cell (GO:0002837) | 3.26697461 |
| 98 | regulation of response to tumor cell (GO:0002834) | 3.26697461 |
| 99 | positive regulation of response to tumor cell (GO:0002836) | 3.26697461 |
| 100 | regulation of activation of Janus kinase activity (GO:0010533) | 3.26607947 |
| 101 | negative regulation by host of viral transcription (GO:0043922) | 3.24452214 |
| 102 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 3.23479578 |
| 103 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 3.21741875 |
| 104 | cellular defense response (GO:0006968) | 3.19629936 |
| 105 | regulation of antigen processing and presentation of peptide antigen (GO:0002583) | 3.16313413 |
| 106 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 3.14485388 |
| 107 | lymph node development (GO:0048535) | 3.13673641 |
| 108 | lymphocyte migration (GO:0072676) | 3.12451376 |
| 109 | ribosomal small subunit assembly (GO:0000028) | 3.12128610 |
| 110 | positive regulation of interleukin-4 production (GO:0032753) | 3.10506194 |
| 111 | B cell receptor signaling pathway (GO:0050853) | 3.08751176 |
| 112 | leukocyte degranulation (GO:0043299) | 3.08313911 |
| 113 | positive regulation of immunoglobulin production (GO:0002639) | 3.07767775 |
| 114 | regulation of defense response to virus by virus (GO:0050690) | 3.07751091 |
| 115 | regulation of T cell mediated immunity (GO:0002709) | 3.07077374 |
| 116 | regulation of alpha-beta T cell activation (GO:0046634) | 3.06688096 |
| 117 | regulation of immunoglobulin production (GO:0002637) | 3.05701825 |
| 118 | regulation of lymphocyte mediated immunity (GO:0002706) | 3.04819480 |
| 119 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 3.04403190 |
| 120 | T-helper cell differentiation (GO:0042093) | 3.04403190 |
| 121 | regulation of chronic inflammatory response (GO:0002676) | 3.04254714 |
| 122 | negative regulation of CD4-positive, alpha-beta T cell activation (GO:2000515) | 3.03375600 |
| 123 | regulation of memory T cell differentiation (GO:0043380) | 3.02529574 |
| 124 | immune response-activating cell surface receptor signaling pathway (GO:0002429) | 3.02169900 |
| 125 | regulation of type I interferon-mediated signaling pathway (GO:0060338) | 3.02030805 |
| 126 | natural killer cell differentiation (GO:0001779) | 3.00154772 |
| 127 | negative regulation of viral genome replication (GO:0045071) | 2.98326877 |
| 128 | chemokine-mediated signaling pathway (GO:0070098) | 2.98226527 |
| 129 | positive regulation of lymphocyte mediated immunity (GO:0002708) | 2.96845719 |
| 130 | negative regulation of adaptive immune response based on somatic recombination of immune receptors b | 2.94314076 |
| 131 | Arp2/3 complex-mediated actin nucleation (GO:0034314) | 2.93208887 |
| 132 | T cell proliferation (GO:0042098) | 2.92357514 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 7.06488827 |
| 2 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 5.98615413 |
| 3 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.35925556 |
| 4 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.97243606 |
| 5 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 3.94027646 |
| 6 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 3.60340201 |
| 7 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 3.47217612 |
| 8 | RUNX_20019798_ChIP-Seq_JUKART_Human | 3.44013532 |
| 9 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 3.43805619 |
| 10 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 3.28285630 |
| 11 | * MYB_26560356_Chip-Seq_TH2_Human | 3.24559244 |
| 12 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.16480607 |
| 13 | MYC_22102868_ChIP-Seq_BL_Human | 2.96500712 |
| 14 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 2.82947455 |
| 15 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 2.79444269 |
| 16 | MAF_26560356_Chip-Seq_TH1_Human | 2.79147843 |
| 17 | MYB_26560356_Chip-Seq_TH1_Human | 2.69621403 |
| 18 | * UTX_26944678_Chip-Seq_JUKART_Human | 2.56989208 |
| 19 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.55554243 |
| 20 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 2.50765468 |
| 21 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.48476873 |
| 22 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 2.40432852 |
| 23 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.30558808 |
| 24 | VDR_21846776_ChIP-Seq_THP-1_Human | 2.19072003 |
| 25 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 2.13504666 |
| 26 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 2.07960286 |
| 27 | GATA3_27048872_Chip-Seq_THYMUS_Human | 2.06393407 |
| 28 | SPI1_23547873_ChIP-Seq_NB4_Human | 2.05596912 |
| 29 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 1.99778135 |
| 30 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.96661670 |
| 31 | MAF_26560356_Chip-Seq_TH2_Human | 1.94178224 |
| 32 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.86000037 |
| 33 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.84137868 |
| 34 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.81244460 |
| 35 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.80301716 |
| 36 | TCF7_22412390_ChIP-Seq_EML_Mouse | 1.79371604 |
| 37 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.77460825 |
| 38 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 1.73104540 |
| 39 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 1.69859246 |
| 40 | E2A_27217539_Chip-Seq_RAMOS-Cell_line_Human | 1.66111419 |
| 41 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.66097189 |
| 42 | KDM2B_26808549_Chip-Seq_HPB-ALL_Human | 1.64983716 |
| 43 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.63529360 |
| 44 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 1.57566202 |
| 45 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.54382095 |
| 46 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.53887925 |
| 47 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.51840699 |
| 48 | CIITA_25753668_ChIP-Seq_RAJI_Human | 1.50051186 |
| 49 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.49876794 |
| 50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.47203191 |
| 51 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.43419735 |
| 52 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 1.41831781 |
| 53 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 1.41822305 |
| 54 | KDM2B_26808549_Chip-Seq_SIL-ALL_Human | 1.39451659 |
| 55 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.39215819 |
| 56 | HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.38024975 |
| 57 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.38011448 |
| 58 | FOXM1_23109430_ChIP-Seq_U2OS_Human | 1.36578975 |
| 59 | * FOXP3_21729870_ChIP-Seq_TREG_Human | 1.34007944 |
| 60 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.33453790 |
| 61 | GATA3_26560356_Chip-Seq_TH2_Human | 1.32809902 |
| 62 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.32608657 |
| 63 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.29534503 |
| 64 | SPI1_23127762_ChIP-Seq_K562_Human | 1.27728485 |
| 65 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.23319503 |
| 66 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.20778152 |
| 67 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.15170661 |
| 68 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.13768369 |
| 69 | GATA2_20887958_ChIP-Seq_HPC-7_Mouse | 1.12522830 |
| 70 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.11034661 |
| 71 | TAL1_20566737_ChIP-Seq_PRIMARY_FETAL_LIVER_ERYTHROID_Mouse | 1.10139623 |
| 72 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.10136157 |
| 73 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.08617390 |
| 74 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.07061718 |
| 75 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.06057444 |
| 76 | TAL1_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04646344 |
| 77 | PU.1_20513432_ChIP-Seq_Bcells_Mouse | 1.04509738 |
| 78 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.03123865 |
| 79 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.03029259 |
| 80 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.01123527 |
| 81 | GATA3_26560356_Chip-Seq_TH1_Human | 1.01108210 |
| 82 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.00622962 |
| 83 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.00293036 |
| 84 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.00096985 |
| 85 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 0.98518543 |
| 86 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.97621063 |
| 87 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 0.97567624 |
| 88 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 0.96556706 |
| 89 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.96166670 |
| 90 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 0.92754818 |
| 91 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.90830225 |
| 92 | RUNX1_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.90678918 |
| 93 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 0.89823481 |
| 94 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.89574303 |
| 95 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 0.88251771 |
| 96 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.87621702 |
| 97 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.86887705 |
| 98 | FLI1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.86574949 |
| 99 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 0.86426575 |
| 100 | VDR_20736230_ChIP-Seq_LYMPHOBLASTOID_Human | 0.85960596 |
| 101 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.84838768 |
| 102 | GATA1_22025678_ChIP-Seq_K562_Human | 0.82760572 |
| 103 | KDM2B_26808549_Chip-Seq_JURKAT_Human | 0.82321533 |
| 104 | * RUNX1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.82274176 |
| 105 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.82103422 |
| 106 | XRN2_22483619_ChIP-Seq_HELA_Human | 0.81201623 |
| 107 | BCL6_27268052_Chip-Seq_Bcells_Human | 0.80297183 |
| 108 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 0.80043496 |
| 109 | SMRT_27268052_Chip-Seq_Bcells_Human | 0.78005058 |
| 110 | PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.76924125 |
| 111 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.76273578 |
| 112 | ETS1_22383799_ChIP-Seq_G1ME_Mouse | 0.75824800 |
| 113 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.75114501 |
| 114 | TCF12/HEB_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.74934552 |
| 115 | IRF1_19129219_ChIP-ChIP_H3396_Human | 0.72463479 |
| 116 | GATA3_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.70597417 |
| 117 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 0.70386114 |
| 118 | VDR_22108803_ChIP-Seq_LS180_Human | 0.70065638 |
| 119 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69632795 |
| 120 | DMRT1_21621532_ChIP-ChIP_FETAL_Ovary | 0.69405269 |
| 121 | GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.69334304 |
| 122 | EBNA2_21746931_ChIP-Seq_IB4-LCL_Human | 0.68991394 |
| 123 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.68693492 |
| 124 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.68473892 |
| 125 | PBX1_22567123_ChIP-ChIP_OVCAR3_Human | 0.68338524 |
| 126 | SOX11_23321250_ChIP-ChIP_Z138-A519-JVM2_Human | 0.67782089 |
| 127 | NCOR1_26117541_ChIP-Seq_K562_Human | 0.67189199 |
| 128 | P300_27268052_Chip-Seq_Bcells_Human | 0.66470741 |
| 129 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.65289832 |
| 130 | RBPJ_21746931_ChIP-Seq_IB4-LCL_Human | 0.64582842 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003763_abnormal_thymus_physiology | 5.62554614 |
| 2 | MP0005671_abnormal_response_to | 4.89901440 |
| 3 | MP0000685_abnormal_immune_system | 3.43612470 |
| 4 | MP0001835_abnormal_antigen_presentation | 3.25500298 |
| 5 | MP0001800_abnormal_humoral_immune | 3.11091626 |
| 6 | MP0009785_altered_susceptibility_to | 3.09057741 |
| 7 | MP0002398_abnormal_bone_marrow | 2.98241981 |
| 8 | MP0002420_abnormal_adaptive_immunity | 2.96889554 |
| 9 | MP0002166_altered_tumor_susceptibility | 2.96669665 |
| 10 | MP0001819_abnormal_immune_cell | 2.92317421 |
| 11 | MP0005000_abnormal_immune_tolerance | 2.86543742 |
| 12 | MP0002723_abnormal_immune_serum | 2.81836452 |
| 13 | MP0002396_abnormal_hematopoietic_system | 2.81085029 |
| 14 | MP0005387_immune_system_phenotype | 2.80527234 |
| 15 | MP0001790_abnormal_immune_system | 2.80527234 |
| 16 | MP0009333_abnormal_splenocyte_physiolog | 2.75191469 |
| 17 | MP0000703_abnormal_thymus_morphology | 2.71774534 |
| 18 | MP0005025_abnormal_response_to | 2.59412584 |
| 19 | MP0002405_respiratory_system_inflammati | 2.58883921 |
| 20 | MP0000716_abnormal_immune_system | 2.55770505 |
| 21 | MP0002452_abnormal_antigen_presenting | 2.54646193 |
| 22 | MP0006082_CNS_inflammation | 2.54145436 |
| 23 | MP0001873_stomach_inflammation | 2.49007479 |
| 24 | MP0002722_abnormal_immune_system | 2.47341926 |
| 25 | MP0003724_increased_susceptibility_to | 2.45502389 |
| 26 | MP0002006_tumorigenesis | 2.45454712 |
| 27 | MP0000689_abnormal_spleen_morphology | 2.35039233 |
| 28 | MP0003866_abnormal_defecation | 2.26431005 |
| 29 | MP0010155_abnormal_intestine_physiology | 2.25551270 |
| 30 | MP0003436_decreased_susceptibility_to | 2.12541340 |
| 31 | MP0002429_abnormal_blood_cell | 2.10994194 |
| 32 | MP0004947_skin_inflammation | 2.08136364 |
| 33 | MP0002148_abnormal_hypersensitivity_rea | 2.03148242 |
| 34 | MP0005464_abnormal_platelet_physiology | 1.94975511 |
| 35 | MP0002419_abnormal_innate_immunity | 1.92764710 |
| 36 | MP0004808_abnormal_hematopoietic_stem | 1.80012458 |
| 37 | MP0002933_joint_inflammation | 1.76753374 |
| 38 | MP0005075_abnormal_melanosome_morpholog | 1.75739806 |
| 39 | MP0000569_abnormal_digit_pigmentation | 1.73112996 |
| 40 | MP0000858_altered_metastatic_potential | 1.72618173 |
| 41 | MP0000465_gastrointestinal_hemorrhage | 1.71973386 |
| 42 | MP0001845_abnormal_inflammatory_respons | 1.70021187 |
| 43 | MP0004381_abnormal_hair_follicle | 1.66795473 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.65842657 |
| 45 | MP0000490_abnormal_crypts_of | 1.54211386 |
| 46 | MP0002009_preneoplasia | 1.51858263 |
| 47 | MP0001853_heart_inflammation | 1.48097970 |
| 48 | MP0003183_abnormal_peptide_metabolism | 1.36618318 |
| 49 | MP0002132_abnormal_respiratory_system | 1.35113194 |
| 50 | MP0003448_altered_tumor_morphology | 1.34899984 |
| 51 | MP0005397_hematopoietic_system_phenotyp | 1.28331779 |
| 52 | MP0001545_abnormal_hematopoietic_system | 1.28331779 |
| 53 | MP0008057_abnormal_DNA_replication | 1.26753184 |
| 54 | MP0002019_abnormal_tumor_incidence | 1.25046918 |
| 55 | MP0004510_myositis | 1.21548105 |
| 56 | MP0005174_abnormal_tail_pigmentation | 1.18449099 |
| 57 | MP0008469_abnormal_protein_level | 1.18418045 |
| 58 | MP0005310_abnormal_salivary_gland | 1.08653677 |
| 59 | MP0010094_abnormal_chromosome_stability | 1.07190777 |
| 60 | MP0003303_peritoneal_inflammation | 1.06902027 |
| 61 | MP0001851_eye_inflammation | 1.06794575 |
| 62 | MP0002163_abnormal_gland_morphology | 1.06230223 |
| 63 | MP0001533_abnormal_skeleton_physiology | 1.01725748 |
| 64 | MP0002277_abnormal_respiratory_mucosa | 1.01527524 |
| 65 | MP0008007_abnormal_cellular_replicative | 0.98318787 |
| 66 | MP0002138_abnormal_hepatobiliary_system | 0.94951293 |
| 67 | MP0003077_abnormal_cell_cycle | 0.91604953 |
| 68 | MP0002998_abnormal_bone_remodeling | 0.85941355 |
| 69 | MP0001986_abnormal_taste_sensitivity | 0.84684666 |
| 70 | MP0010352_gastrointestinal_tract_polyps | 0.81366043 |
| 71 | MP0008058_abnormal_DNA_repair | 0.81218005 |
| 72 | MP0002876_abnormal_thyroid_physiology | 0.80633035 |
| 73 | MP0009763_increased_sensitivity_to | 0.79124525 |
| 74 | MP0004742_abnormal_vestibular_system | 0.76752676 |
| 75 | MP0002095_abnormal_skin_pigmentation | 0.76415565 |
| 76 | MP0004957_abnormal_blastocyst_morpholog | 0.72571932 |
| 77 | MP0008877_abnormal_DNA_methylation | 0.71712184 |
| 78 | MP0003693_abnormal_embryo_hatching | 0.71704591 |
| 79 | MP0000015_abnormal_ear_pigmentation | 0.71427523 |
| 80 | MP0001501_abnormal_sleep_pattern | 0.69437360 |
| 81 | MP0009765_abnormal_xenobiotic_induced | 0.68739730 |
| 82 | MP0009764_decreased_sensitivity_to | 0.68156785 |
| 83 | MP0003045_fibrosis | 0.67786546 |
| 84 | MP0000477_abnormal_intestine_morphology | 0.65533292 |
| 85 | MP0001765_abnormal_ion_homeostasis | 0.63486356 |
| 86 | MP0005023_abnormal_wound_healing | 0.62496877 |
| 87 | MP0000604_amyloidosis | 0.61606558 |
| 88 | MP0001243_abnormal_dermal_layer | 0.61452344 |
| 89 | MP0001919_abnormal_reproductive_system | 0.58948339 |
| 90 | MP0009278_abnormal_bone_marrow | 0.57352880 |
| 91 | MP0005390_skeleton_phenotype | 0.57276885 |
| 92 | MP0000372_irregular_coat_pigmentation | 0.55810717 |
| 93 | MP0005377_hearing/vestibular/ear_phenot | 0.55442174 |
| 94 | MP0003878_abnormal_ear_physiology | 0.55442174 |
| 95 | MP0001663_abnormal_digestive_system | 0.55145864 |
| 96 | MP0000609_abnormal_liver_physiology | 0.54746019 |
| 97 | MP0004130_abnormal_muscle_cell | 0.53410920 |
| 98 | MP0005379_endocrine/exocrine_gland_phen | 0.53276829 |
| 99 | MP0002877_abnormal_melanocyte_morpholog | 0.52024666 |
| 100 | MP0003795_abnormal_bone_structure | 0.51177893 |
| 101 | MP0003111_abnormal_nucleus_morphology | 0.50680345 |
| 102 | MP0001191_abnormal_skin_condition | 0.50101939 |
| 103 | MP0008872_abnormal_physiological_respon | 0.48289716 |
| 104 | MP0000313_abnormal_cell_death | 0.47649030 |
| 105 | MP0000249_abnormal_blood_vessel | 0.47033099 |
| 106 | MP0003828_pulmonary_edema | 0.46997252 |
| 107 | MP0003252_abnormal_bile_duct | 0.46615470 |
| 108 | MP0008873_increased_physiological_sensi | 0.46529404 |
| 109 | MP0002136_abnormal_kidney_physiology | 0.45843999 |
| 110 | MP0003646_muscle_fatigue | 0.45619956 |
| 111 | MP0005166_decreased_susceptibility_to | 0.44001724 |
| 112 | MP0000343_altered_response_to | 0.42932434 |
| 113 | MP0009643_abnormal_urine_homeostasis | 0.42317886 |
| 114 | MP0001216_abnormal_epidermal_layer | 0.42026397 |
| 115 | MP0010307_abnormal_tumor_latency | 0.41036245 |
| 116 | MP0000367_abnormal_coat/_hair | 0.39415566 |
| 117 | MP0002083_premature_death | 0.38139674 |
| 118 | MP0003943_abnormal_hepatobiliary_system | 0.38005228 |
| 119 | MP0008961_abnormal_basal_metabolism | 0.37481623 |
| 120 | MP0001348_abnormal_lacrimal_gland | 0.37148866 |
| 121 | MP0002693_abnormal_pancreas_physiology | 0.35179171 |
| 122 | MP0000598_abnormal_liver_morphology | 0.35144040 |
| 123 | MP0006054_spinal_hemorrhage | 0.35039560 |
| 124 | MP0003172_abnormal_lysosome_physiology | 0.33775129 |
| 125 | MP0003786_premature_aging | 0.32968521 |
| 126 | MP0008770_decreased_survivor_rate | 0.32947090 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | T lymphocytopenia (HP:0005403) | 8.06117663 |
| 2 | Abnormality of T cell number (HP:0011839) | 7.66187782 |
| 3 | Severe combined immunodeficiency (HP:0004430) | 6.03292657 |
| 4 | Combined immunodeficiency (HP:0005387) | 5.63381170 |
| 5 | Abnormality of T cells (HP:0002843) | 5.61739879 |
| 6 | Elevated erythrocyte sedimentation rate (HP:0003565) | 5.57173078 |
| 7 | Recurrent bronchitis (HP:0002837) | 5.09874998 |
| 8 | IgM deficiency (HP:0002850) | 4.89566144 |
| 9 | Myositis (HP:0100614) | 4.69599516 |
| 10 | IgG deficiency (HP:0004315) | 4.62716765 |
| 11 | Nasal polyposis (HP:0100582) | 4.59895078 |
| 12 | Panhypogammaglobulinemia (HP:0003139) | 4.50943056 |
| 13 | Recurrent viral infections (HP:0004429) | 4.47506929 |
| 14 | Chronic otitis media (HP:0000389) | 4.44666376 |
| 15 | Thyroiditis (HP:0100646) | 4.40237935 |
| 16 | Abnormality of eosinophils (HP:0001879) | 4.27356261 |
| 17 | Recurrent fungal infections (HP:0002841) | 4.21372077 |
| 18 | Autoimmune hemolytic anemia (HP:0001890) | 4.14243733 |
| 19 | Stomatitis (HP:0010280) | 4.13693899 |
| 20 | Abnormality of B cell number (HP:0010975) | 4.13200693 |
| 21 | B lymphocytopenia (HP:0010976) | 4.13200693 |
| 22 | Hypoplasia of the thymus (HP:0000778) | 3.96475781 |
| 23 | Abnormality of the nasal mucosa (HP:0000433) | 3.88719686 |
| 24 | Eosinophilia (HP:0001880) | 3.85964694 |
| 25 | Leukocytosis (HP:0001974) | 3.60412646 |
| 26 | Abnormality of the fingertips (HP:0001211) | 3.59238751 |
| 27 | Retrobulbar optic neuritis (HP:0100654) | 3.57402200 |
| 28 | Optic neuritis (HP:0100653) | 3.57402200 |
| 29 | Lymphopenia (HP:0001888) | 3.50255800 |
| 30 | Abnormality of T cell physiology (HP:0011840) | 3.46561948 |
| 31 | Chronic mucocutaneous candidiasis (HP:0002728) | 3.44552028 |
| 32 | Recurrent cutaneous fungal infections (HP:0011370) | 3.44552028 |
| 33 | Granulocytopenia (HP:0001913) | 3.44201500 |
| 34 | Abnormality of cells of the lymphoid lineage (HP:0012140) | 3.38086681 |
| 35 | Chronic diarrhea (HP:0002028) | 3.31173326 |
| 36 | Thrombocytosis (HP:0001894) | 3.22192866 |
| 37 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 3.19612058 |
| 38 | Orchitis (HP:0100796) | 3.17772654 |
| 39 | Meningitis (HP:0001287) | 3.15601875 |
| 40 | Joint swelling (HP:0001386) | 3.08211319 |
| 41 | Bronchitis (HP:0012387) | 3.07509647 |
| 42 | Encephalitis (HP:0002383) | 3.02180329 |
| 43 | Pustule (HP:0200039) | 2.96234842 |
| 44 | Lymphoma (HP:0002665) | 2.92707157 |
| 45 | Increased IgM level (HP:0003496) | 2.91571546 |
| 46 | Stomach cancer (HP:0012126) | 2.91495434 |
| 47 | Vasculitis (HP:0002633) | 2.86338886 |
| 48 | Hemoptysis (HP:0002105) | 2.85309762 |
| 49 | Keratoconjunctivitis sicca (HP:0001097) | 2.84871400 |
| 50 | Recurrent abscess formation (HP:0002722) | 2.82121584 |
| 51 | Petechiae (HP:0000967) | 2.80356831 |
| 52 | Abnormality of macrophages (HP:0004311) | 2.79859642 |
| 53 | Autoimmune thrombocytopenia (HP:0001973) | 2.79555672 |
| 54 | Eczematoid dermatitis (HP:0000976) | 2.78451405 |
| 55 | Pulmonary infiltrates (HP:0002113) | 2.75865881 |
| 56 | Gastrointestinal infarctions (HP:0005244) | 2.68409321 |
| 57 | Recurrent sinusitis (HP:0011108) | 2.67748359 |
| 58 | Abnormality of the prostate (HP:0008775) | 2.60436555 |
| 59 | Epistaxis (HP:0000421) | 2.58583958 |
| 60 | Mediastinal lymphadenopathy (HP:0100721) | 2.57903319 |
| 61 | Keratoconjunctivitis (HP:0001096) | 2.56622254 |
| 62 | Prolonged bleeding time (HP:0003010) | 2.53731648 |
| 63 | Papilledema (HP:0001085) | 2.52292062 |
| 64 | IgA deficiency (HP:0002720) | 2.51670732 |
| 65 | Hypergammaglobulinemia (HP:0010702) | 2.49797149 |
| 66 | Alveolar cell carcinoma (HP:0006519) | 2.41761840 |
| 67 | Arterial thrombosis (HP:0004420) | 2.41356298 |
| 68 | Spontaneous hematomas (HP:0007420) | 2.37770585 |
| 69 | Increased IgE level (HP:0003212) | 2.37673381 |
| 70 | Hypoproteinemia (HP:0003075) | 2.35892960 |
| 71 | Abnormal platelet volume (HP:0011876) | 2.35892480 |
| 72 | Hypochromic anemia (HP:0001931) | 2.32815900 |
| 73 | Recurrent skin infections (HP:0001581) | 2.32596280 |
| 74 | Chronic obstructive pulmonary disease (HP:0006510) | 2.31928481 |
| 75 | Obstructive lung disease (HP:0006536) | 2.31928481 |
| 76 | Basal cell carcinoma (HP:0002671) | 2.31592483 |
| 77 | Hemiplegia (HP:0002301) | 2.30324185 |
| 78 | Inflammation of the large intestine (HP:0002037) | 2.28133077 |
| 79 | Aplasia/Hypoplasia of the thymus (HP:0010515) | 2.26688889 |
| 80 | Agammaglobulinemia (HP:0004432) | 2.25980162 |
| 81 | Gastrointestinal inflammation (HP:0004386) | 2.21348019 |
| 82 | Abnormality of the pleura (HP:0002103) | 2.21058616 |
| 83 | Pancytopenia (HP:0001876) | 2.20888086 |
| 84 | Pulmonary embolism (HP:0002204) | 2.20761399 |
| 85 | Neoplasm of the tracheobronchial system (HP:0100552) | 2.19777572 |
| 86 | Neutropenia (HP:0001875) | 2.19244206 |
| 87 | Aplastic anemia (HP:0001915) | 2.14161937 |
| 88 | Gingival bleeding (HP:0000225) | 2.13049197 |
| 89 | Chronic sinusitis (HP:0011109) | 2.12980942 |
| 90 | Recurrent otitis media (HP:0000403) | 2.11265465 |
| 91 | Bronchiectasis (HP:0002110) | 2.07783531 |
| 92 | Pulmonary fibrosis (HP:0002206) | 2.05898987 |
| 93 | Gangrene (HP:0100758) | 2.05870499 |
| 94 | Chest pain (HP:0100749) | 2.04475354 |
| 95 | Poikiloderma (HP:0001029) | 2.01070266 |
| 96 | Acute hepatic failure (HP:0006554) | 1.99970705 |
| 97 | Amaurosis fugax (HP:0100576) | 1.98329961 |
| 98 | Increased density of long bones (HP:0006392) | 1.95169072 |
| 99 | Anorexia (HP:0002039) | 1.94289271 |
| 100 | Glomerulopathy (HP:0100820) | 1.94270424 |
| 101 | Increased mean platelet volume (HP:0011877) | 1.92909998 |
| 102 | Recurrent bacterial skin infections (HP:0005406) | 1.92137120 |
| 103 | Ureteral stenosis (HP:0000071) | 1.91878745 |
| 104 | Abnormal number of erythroid precursors (HP:0012131) | 1.91241971 |
| 105 | Abnormality of cells of the erythroid lineage (HP:0012130) | 1.90919538 |
| 106 | Entropion (HP:0000621) | 1.89672343 |
| 107 | Purpura (HP:0000979) | 1.89364286 |
| 108 | Impaired platelet aggregation (HP:0003540) | 1.89239791 |
| 109 | Abnormal platelet function (HP:0011869) | 1.89239791 |
| 110 | Polyneuropathy (HP:0001271) | 1.85421920 |
| 111 | Verrucae (HP:0200043) | 1.84767411 |
| 112 | Papilloma (HP:0012740) | 1.84767411 |
| 113 | Keratitis (HP:0000491) | 1.84636199 |
| 114 | Skin rash (HP:0000988) | 1.82120076 |
| 115 | Ureteral obstruction (HP:0006000) | 1.80208874 |
| 116 | Supernumerary bones of the axial skeleton (HP:0009144) | 1.77366890 |
| 117 | Urticaria (HP:0001025) | 1.77022651 |
| 118 | Increased CSF protein (HP:0002922) | 1.76933327 |
| 119 | Arthralgia (HP:0002829) | 1.76886762 |
| 120 | Conical tooth (HP:0000698) | 1.73728507 |
| 121 | Abnormality of male internal genitalia (HP:0000022) | 1.72834542 |
| 122 | Gingivitis (HP:0000230) | 1.68236747 |
| 123 | Abnormality of binocular vision (HP:0011514) | 1.67622164 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TXK | 7.32932447 |
| 2 | MAP4K1 | 5.57988672 |
| 3 | ITK | 3.50155649 |
| 4 | ZAP70 | 3.11975592 |
| 5 | JAK3 | 2.79526469 |
| 6 | STK10 | 2.62766540 |
| 7 | IKBKE | 2.41126704 |
| 8 | TEC | 2.33776956 |
| 9 | FGFR4 | 2.24156297 |
| 10 | TYK2 | 2.16080291 |
| 11 | GRK6 | 2.13018652 |
| 12 | NLK | 2.04354604 |
| 13 | LCK | 1.92933092 |
| 14 | RIPK4 | 1.91119704 |
| 15 | BTK | 1.83298349 |
| 16 | KIT | 1.82796541 |
| 17 | JAK1 | 1.82263119 |
| 18 | EEF2K | 1.77669030 |
| 19 | TBK1 | 1.69455764 |
| 20 | CSK | 1.58350723 |
| 21 | SYK | 1.57935797 |
| 22 | MST4 | 1.50466743 |
| 23 | MAP3K14 | 1.49004751 |
| 24 | FGFR3 | 1.48048252 |
| 25 | BMPR2 | 1.41932988 |
| 26 | TAOK3 | 1.40365577 |
| 27 | NME2 | 1.38708605 |
| 28 | IRAK4 | 1.37649356 |
| 29 | PIM1 | 1.26662691 |
| 30 | HCK | 1.24054338 |
| 31 | FLT3 | 1.23960657 |
| 32 | TESK2 | 1.17638446 |
| 33 | LRRK2 | 1.14637568 |
| 34 | KDR | 1.14163508 |
| 35 | TNK2 | 1.10768797 |
| 36 | PRKCQ | 1.09152449 |
| 37 | MAP3K12 | 1.06946693 |
| 38 | MARK3 | 0.96096550 |
| 39 | PKN2 | 0.94977372 |
| 40 | TGFBR2 | 0.93083160 |
| 41 | CLK1 | 0.92673497 |
| 42 | SCYL2 | 0.92124541 |
| 43 | IKBKB | 0.91639284 |
| 44 | ADRBK2 | 0.88995640 |
| 45 | CAMKK1 | 0.87595892 |
| 46 | GRK7 | 0.84396040 |
| 47 | BLK | 0.84113468 |
| 48 | FES | 0.83746372 |
| 49 | LYN | 0.83068344 |
| 50 | MAP4K2 | 0.82524234 |
| 51 | PIK3CG | 0.82014571 |
| 52 | PRKCH | 0.80909207 |
| 53 | PIM2 | 0.80094428 |
| 54 | RPS6KA4 | 0.79216496 |
| 55 | JAK2 | 0.76263184 |
| 56 | CSF1R | 0.75381916 |
| 57 | CDK4 | 0.74012621 |
| 58 | MAP3K10 | 0.70301651 |
| 59 | MUSK | 0.65760415 |
| 60 | MAP2K2 | 0.64409112 |
| 61 | MAP3K11 | 0.63892303 |
| 62 | MAP3K13 | 0.62990161 |
| 63 | MATK | 0.59363822 |
| 64 | CHUK | 0.57830893 |
| 65 | MAP3K7 | 0.57481898 |
| 66 | TNIK | 0.57264281 |
| 67 | SIK2 | 0.56968989 |
| 68 | PRPF4B | 0.56887818 |
| 69 | SIK3 | 0.55972563 |
| 70 | ACVR1B | 0.54954763 |
| 71 | TGFBR1 | 0.54891606 |
| 72 | CDC7 | 0.52868079 |
| 73 | NUAK1 | 0.52529789 |
| 74 | RPS6KB2 | 0.52035362 |
| 75 | PIK3CA | 0.50466289 |
| 76 | BUB1 | 0.49778885 |
| 77 | HIPK2 | 0.49392868 |
| 78 | TSSK6 | 0.47891339 |
| 79 | CDK6 | 0.46737116 |
| 80 | TLK1 | 0.46511011 |
| 81 | PDGFRB | 0.45896211 |
| 82 | STK4 | 0.41416487 |
| 83 | MAP2K6 | 0.41214398 |
| 84 | BCKDK | 0.40926786 |
| 85 | NEK6 | 0.40298606 |
| 86 | MAPK11 | 0.39999117 |
| 87 | MAPK12 | 0.39720123 |
| 88 | PDK1 | 0.38507147 |
| 89 | ZAK | 0.38221261 |
| 90 | RAF1 | 0.37901079 |
| 91 | MAP2K3 | 0.36964374 |
| 92 | PRKD2 | 0.36731743 |
| 93 | MAPK4 | 0.36278281 |
| 94 | FYN | 0.35818982 |
| 95 | IGF1R | 0.35166160 |
| 96 | ATR | 0.34391953 |
| 97 | PASK | 0.34159480 |
| 98 | MELK | 0.34092266 |
| 99 | IRAK3 | 0.33973938 |
| 100 | MAPKAPK2 | 0.33732398 |
| 101 | EIF2AK1 | 0.33630388 |
| 102 | WNK4 | 0.33214443 |
| 103 | CAMKK2 | 0.32535173 |
| 104 | NEK9 | 0.31605790 |
| 105 | CDK9 | 0.31462043 |
| 106 | MAPK7 | 0.31081216 |
| 107 | IRAK1 | 0.30931813 |
| 108 | TYRO3 | 0.30591086 |
| 109 | MAPKAPK3 | 0.29643062 |
| 110 | TRPM7 | 0.29218379 |
| 111 | GRK1 | 0.29031605 |
| 112 | RPS6KA6 | 0.28542961 |
| 113 | MAPK3 | 0.28479492 |
| 114 | MAP3K3 | 0.27886933 |
| 115 | FRK | 0.26520870 |
| 116 | TAOK1 | 0.25271036 |
| 117 | EPHA3 | 0.25238191 |
| 118 | EPHB1 | 0.24943161 |
| 119 | INSR | 0.22786647 |
| 120 | ILK | 0.21831421 |
| 121 | MARK2 | 0.21790221 |
| 122 | TESK1 | 0.20911825 |
| 123 | PINK1 | 0.20569004 |
| 124 | NEK2 | 0.20521839 |
| 125 | FGR | 0.20439316 |
| 126 | RPS6KA5 | 0.19416715 |
| 127 | EIF2AK3 | 0.19056735 |
| 128 | BRSK2 | 0.18630690 |
| 129 | RPS6KL1 | 0.18486588 |
| 130 | RPS6KC1 | 0.18486588 |
| 131 | PAK3 | 0.17047545 |
| 132 | MAP3K1 | 0.16382541 |
| 133 | TAOK2 | 0.16355926 |
| 134 | ABL1 | 0.15792391 |
| 135 | EGFR | 0.15621143 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Primary immunodeficiency_Homo sapiens_hsa05340 | 5.80287956 |
| 2 | Graft-versus-host disease_Homo sapiens_hsa05332 | 3.78514859 |
| 3 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 3.68587200 |
| 4 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 3.62783359 |
| 5 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 3.14941017 |
| 6 | Antigen processing and presentation_Homo sapiens_hsa04612 | 3.05032990 |
| 7 | Measles_Homo sapiens_hsa05162 | 2.75537219 |
| 8 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 2.65788699 |
| 9 | Allograft rejection_Homo sapiens_hsa05330 | 2.60191769 |
| 10 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 2.28893061 |
| 11 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.27416519 |
| 12 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.84281409 |
| 13 | Leishmaniasis_Homo sapiens_hsa05140 | 1.80164043 |
| 14 | Ribosome_Homo sapiens_hsa03010 | 1.77792942 |
| 15 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.73466349 |
| 16 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.72282716 |
| 17 | DNA replication_Homo sapiens_hsa03030 | 1.70876362 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.70102124 |
| 19 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.68241716 |
| 20 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.59853427 |
| 21 | Non-homologous end-joining_Homo sapiens_hsa03450 | 1.58936468 |
| 22 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.56536214 |
| 23 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.54193724 |
| 24 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.24923430 |
| 25 | Mismatch repair_Homo sapiens_hsa03430 | 1.22168273 |
| 26 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 1.21506141 |
| 27 | Hepatitis B_Homo sapiens_hsa05161 | 1.20333745 |
| 28 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.19938090 |
| 29 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.18179567 |
| 30 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 1.17793685 |
| 31 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.16333234 |
| 32 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 1.15668194 |
| 33 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.13852689 |
| 34 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.06743206 |
| 35 | Spliceosome_Homo sapiens_hsa03040 | 1.05831611 |
| 36 | Shigellosis_Homo sapiens_hsa05131 | 1.05692461 |
| 37 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.05544385 |
| 38 | Apoptosis_Homo sapiens_hsa04210 | 1.03659501 |
| 39 | HTLV-I infection_Homo sapiens_hsa05166 | 1.02880731 |
| 40 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 1.02415013 |
| 41 | Influenza A_Homo sapiens_hsa05164 | 0.99124869 |
| 42 | Base excision repair_Homo sapiens_hsa03410 | 0.98174569 |
| 43 | Colorectal cancer_Homo sapiens_hsa05210 | 0.92502264 |
| 44 | Asthma_Homo sapiens_hsa05310 | 0.91561347 |
| 45 | Platelet activation_Homo sapiens_hsa04611 | 0.91148842 |
| 46 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.90854954 |
| 47 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.88208103 |
| 48 | Legionellosis_Homo sapiens_hsa05134 | 0.87783003 |
| 49 | TNF signaling pathway_Homo sapiens_hsa04668 | 0.86640618 |
| 50 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.85373129 |
| 51 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 0.83090710 |
| 52 | Epstein-Barr virus infection_Homo sapiens_hsa05169 | 0.79690421 |
| 53 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.79457173 |
| 54 | Nucleotide excision repair_Homo sapiens_hsa03420 | 0.79370771 |
| 55 | RNA degradation_Homo sapiens_hsa03018 | 0.75317080 |
| 56 | Malaria_Homo sapiens_hsa05144 | 0.74799342 |
| 57 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 0.74540134 |
| 58 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.72897993 |
| 59 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 0.71414495 |
| 60 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.71100975 |
| 61 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.69271794 |
| 62 | Thyroid cancer_Homo sapiens_hsa05216 | 0.65284898 |
| 63 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.64982716 |
| 64 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.63449682 |
| 65 | Hepatitis C_Homo sapiens_hsa05160 | 0.61449112 |
| 66 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.56597498 |
| 67 | Homologous recombination_Homo sapiens_hsa03440 | 0.56092652 |
| 68 | Tuberculosis_Homo sapiens_hsa05152 | 0.55938542 |
| 69 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.53374249 |
| 70 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.53331009 |
| 71 | Cell cycle_Homo sapiens_hsa04110 | 0.52625139 |
| 72 | Salmonella infection_Homo sapiens_hsa05132 | 0.52077619 |
| 73 | Pertussis_Homo sapiens_hsa05133 | 0.51831875 |
| 74 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.51621371 |
| 75 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.51290338 |
| 76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50840278 |
| 77 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.50179770 |
| 78 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.49689939 |
| 79 | Other glycan degradation_Homo sapiens_hsa00511 | 0.47913068 |
| 80 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.47059331 |
| 81 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.45250578 |
| 82 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.44103679 |
| 83 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 0.42344082 |
| 84 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.41718296 |
| 85 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.38938490 |
| 86 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.38552002 |
| 87 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38488962 |
| 88 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 0.37254021 |
| 89 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.36243390 |
| 90 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.35488134 |
| 91 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 0.35105162 |
| 92 | Endocytosis_Homo sapiens_hsa04144 | 0.33119120 |
| 93 | Notch signaling pathway_Homo sapiens_hsa04330 | 0.32755124 |
| 94 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.31931360 |
| 95 | mRNA surveillance pathway_Homo sapiens_hsa03015 | 0.31701278 |
| 96 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 0.31120718 |
| 97 | Proteasome_Homo sapiens_hsa03050 | 0.30352866 |
| 98 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.28536555 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.28050035 |
| 100 | RNA transport_Homo sapiens_hsa03013 | 0.27350295 |
| 101 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.23646117 |
| 102 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.22698587 |
| 103 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.21317998 |
| 104 | Rap1 signaling pathway_Homo sapiens_hsa04015 | 0.20971166 |
| 105 | Phototransduction_Homo sapiens_hsa04744 | 0.19834378 |
| 106 | Endometrial cancer_Homo sapiens_hsa05213 | 0.19419912 |
| 107 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.19116781 |
| 108 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.19003703 |
| 109 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.18232824 |
| 110 | RNA polymerase_Homo sapiens_hsa03020 | 0.18167152 |
| 111 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.17371937 |
| 112 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.17335627 |
| 113 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.17273354 |
| 114 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.16492747 |
| 115 | Pathways in cancer_Homo sapiens_hsa05200 | 0.16433901 |
| 116 | Basal transcription factors_Homo sapiens_hsa03022 | 0.16175204 |
| 117 | Insulin resistance_Homo sapiens_hsa04931 | 0.14411905 |
| 118 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 0.14252692 |
| 119 | Circadian rhythm_Homo sapiens_hsa04710 | 0.13807420 |
| 120 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.12075673 |
| 121 | Phagosome_Homo sapiens_hsa04145 | 0.11933622 |
| 122 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.10164892 |
| 123 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.10008200 |
| 124 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.09942351 |
| 125 | Lysosome_Homo sapiens_hsa04142 | 0.09672915 |
| 126 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.08869989 |
| 127 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.08491446 |
| 128 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.07436819 |

